Barclays analyst Lauren Lieberman raised the firm’s price target on Procter & Gamble to $170 from $168 and keeps an Overweight rating on the shares. The company’s fiscal Q3 results felt similar to Q2 with respect to being “better than muted expectations heading into the print,” the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble’s Bold Buyback: Balancing Share Repurchases with Financial Health Risks
- PG Earnings: Procter & Gamble’s Q3 Revenues Disappoint
- Procter & Gamble: Uncovering Hidden Gems for Market Growth
- Procter & Gamble expects oil, diesel, pulp costs to impact Q4
- Unusually active option classes on open April 19th